Réus, Gislaine Zilli <br/><br/>
Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.  [electronic resource] 

 -  Current neurovascular research  2016 
 - 107-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-5739 
<br/><br/><label>Standard No.: </label>10.2174/1567202613666160219115832  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Antioxidants--pharmacology<br/>Brain--drug effects<br/>Brain-Derived Neurotrophic Factor--metabolism<br/>Deferoxamine--pharmacology<br/>Diabetes Mellitus, Experimental--drug therapy<br/>MAP Kinase Kinase 4--metabolism<br/>Rats<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism